Evidence map›Paper›PMID 35193594›Full record

ArticleJournal of neuroinflammation2022

α-Synuclein-containing erythrocytic extracellular vesicles: essential contributors to hyperactivation of monocytes in Parkinson's disease.

Zongran Liu, Robin Barry Chan, Zhijian Cai, Xiaodan Liu, Yufeng Wu, Zhenwei Yu, Tao Feng, Ying Yang, Jing Zhang

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Peripheral proteinopathy in neurodegenerative diseases.Translational neurodegeneration · 2025
    Review
  18. Review
  19. Review
  20. Biomimetic erythrocyte-based drug delivery systems for organ-targeted therapy.Frontiers in bioengineering and biotechnology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Zongran LiuDepartment of Pathology, Peking University Health Science Center, Beijing, 100191, China.
Robin Barry ChanAliveX Biotech, Shanghai, 200030, China.
Zhijian CaiSchool of Basic Medicine, Zhejiang University, Hangzhou, 310002, Zhejiang, China.
Xiaodan LiuDepartment of Pathology, Peking University Health Science Center, Beijing, 100191, China.
Yufeng WuDepartment of Laboratory Medicine, Peking University Third Hospital, Peking University Health Science Center, Beijing, China.
Zhenwei YuBeijing Neurosurgical Institute, Capital Medical University, Beijing, 100050, China.
Tao FengDepartment of Neurology, TianTan Hospital, Capital Medical University, Beijing, 100050, China.
Ying YangDepartment of Pathology, Peking University Health Science Center, Beijing, 100191, China. rebecca_yang@pku.edu.cn.
Jing ZhangDepartment of Pathology, Zhejiang University School of Medicine and First Affiliated Hospital, Hangzhou, 310002, Zhejiang, China. jzhang1989@zju.edu.cn.ORCID http://orcid.org/0000-0002-9224-6299
Peking University · CNCapital Medical University · CNFirst Affiliated Hospital Zhejiang University · CNZhejiang University · CN

Funding

National Key Research and Development Program of China 2016YFC1306500National Natural Science Foundation of China 81571226National Natural Science Foundation of China 81671187National Natural Science Foundation of China 82001200National Natural Science Foundation of China 82020108012Postdoctoral Research Foundation of China 2020M670063Postdoctoral Research Foundation of China 2020T130030
6 · The paper itself

Abstract

backgroundImmune system dysfunction, including higher levels of peripheral monocytes and inflammatory cytokines, is an important feature of Parkinson's disease (PD) pathogenesis, although the mechanism underlying the process remains to be investigated. In the central nervous system, it is well-known that α-synuclein (α-syn), a key protein involved in PD, activates microglia potently, and it is also reported that α-syn exists in the peripheral system, especially in erythrocytes or red blood cells (RBC) at exceedingly high concentration. The current study focused on the possibility that RBC-derived α-syn mediates the sensitization of peripheral monocytes in PD patients.

methodsThe hyperactivation of monocytes was assessed quantitatively by measuring mRNA levels of typical inflammatory cytokines (including IL-1β, IL-6 and TNF-α) and protein levels of secreted inflammatory cytokines (including pro-inflammatory cytokines: IL-1β, IL-6, TNF-α, IL-8, IFN-γ, IL-2, and IL-12p70 and anti-inflammatory cytokines: IL-4, IL-10, and IL-13). Western blot, nanoparticle tracking analysis and electron microscopy were used to characterize RBC-derived extracellular vesicles (RBC-EVs). Inhibitors of endocytosis and leucine-rich repeat kinase 2 (LRRK2), another key protein involved in PD, were used to investigate how these two factors mediated the process of monocyte sensitization by RBC-EVs.

resultsIncreased inflammatory sensitization of monocytes was observed in PD patients and PD model mice. We found that α-syn-containing RBC-EVs isolated from PD model mice or free form oligomeric α-syn induced the inflammatory sensitization of THP-1 cells, and demonstrated that endocytosis was a requirement for this pathophysiological pathway. Furthermore, the hyperactivation of THP-1 cells induced by RBC-EVs was associated with increased LRRK2 production and kinase activity. The phenomenon of inflammatory sensitization of human monocytes and increased LRRK2 were also observed by the treatment of RBC-EVs isolated from PD patients.

conclusionsOur data provided new insight into how hyperactivation of monocytes occurs in PD patients, and identified the central role played by α-syn-containing RBC-EVs in this process.

Indexed as

Extracellular VesiclesParkinson Diseasealpha-SynucleinAnimalsErythrocytesHumansMiceMonocytesalpha-SynucleinExtracellular vesiclesLRRK2MonocytesParkinson’s diseaseRBCα-Synuclein

Identifiers

PMID35193594
PMCPMC8862590
OpenAlexW4213329103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.